Ownership history in Caption Management, LLC · 10 quarters on record
This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in NEWAMSTERDAM PHARMA COMPANY (NAMS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 75,000 | +65,472 | +687.2% | 0.02% | $2.6M | $35.08 |
| 2025 Q4 | REDUCED | 9,528 | -1,160,172 | -99.2% | 0.00% | $334K | $35.08 |
| 2025 Q3 | ADDED | 1,169,700 | +1,158,600 | +10437.8% | 0.26% | $33.3M | $28.44 |
| 2025 Q3 | ADDED | 11,100 | +5,100 | +85.0% | 0.00% | $316K | $28.44 |
| 2025 Q2 | REDUCED | 6,000 | -24,000 | -80.0% | 0.00% | $109K | $18.11 |
| 2025 Q2 | REDUCED | 30,000 | -934 | -3.0% | 0.01% | $543K | $18.11 |
| 2025 Q1 | REDUCED | 30,934 | -113,644 | -78.6% | 0.01% | $633K | $20.47 |
| 2024 Q4 | REDUCED | 144,578 | -55,322 | -27.7% | 0.04% | $3.7M | $25.70 |
| 2024 Q4 | ADDED | 199,900 | +157,400 | +370.4% | 0.05% | $5.1M | $25.70 |
| 2024 Q4 | INITIATED | 42,500 | — | — | 0.01% | $1.1M | $25.70 |
As of 2025 Q4 — sorted by position size